OIC
REGN icon

Orion Investment Company’s Regeneron Pharmaceuticals REGN Stock Holding History

Orion Investment Company’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.4M Sell
29,501
-1,336
-4% -$909K 5.37% 4
2026
Q1 		$23.8M Buy
30,837
+25
+0.1% +$19.1K 7.56% 2
2025
Q4 		$23.8M Buy
30,812
+175
+0.6% +$119K 7.25% 3
2025
Q3 		$17.2M Buy
30,637
+366
+1% +$207K 5.47% 4
2025
Q2 		$15.9M Sell
30,271
-290
-0.9% -$162K 5.63% 4
2025
Q1 		$19.4M Buy
30,561
+675
+2% +$464K 7.92% 2
2024
Q4 		$21.3M Buy
29,886
+500
+2% +$420K 8.49% 2
2024
Q3 		$30.9M Sell
29,386
-102
-0.3% -$114K 12.01% 2
2024
Q2 		$31M Buy
+29,488
New +$28.6M 12.35% 2

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Orion Investment Company's REGN Position: Q2 2026 in Review

Orion Investment Company reduced its Regeneron Pharmaceuticals (REGN) stake by 4.3% in Q2 2026, selling an estimated $909K and leaving 29,501 shares worth $18.4M. The position accounts for 5.37% of the portfolio, ranked #4.

Orion Investment Company first reported a position in REGN in Q2 2024 and has held it in 9 quarters since. The position peaked at $31M in Q2 2024. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Orion Investment Company held 29,501 shares of Regeneron Pharmaceuticals worth $18.4M as of Q2 2026.
  • Orion Investment Company sold 1,336 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $909K.
  • Regeneron Pharmaceuticals made up 5.37% of Orion Investment Company's portfolio in Q2 2026, its #4 holding.
  • Orion Investment Company first reported a position in Regeneron Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • Orion Investment Company's Regeneron Pharmaceuticals position peaked at $31M in Q2 2024.
  • 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Orion Investment Company's 13F filing for Q2 2026, filed 11 Aug 2026.